Insights from Mouse Models to Understand Neurodegeneration in Down Syndrome

E-ISSN： 1996-3181|9|4|429-438

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.9, Iss.4, 2010-08, pp. : 429-438

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oncogene-Blocking Therapies: New Insights from Conditional Mouse Tumor Models

Current Cancer Drug Targets, Vol. 6, Iss. 7, 2006-11 ,pp. : 603-612

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoprotein Size and Susceptibility to Atherosclerosis — Insights from Genetically Modified Mouse Models

Current Drug Targets, Vol. 9, Iss. 3, 2008-03 ,pp. : 174-189

Bentham Science Publishers

Access to resources Recommend Favorite

Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models

By Rivera Jennifer Sobey Christopher G. Walduck Anna K. Drummond Grant R.

Redox Report, Vol. 15, Iss. 2, 2010-04 ,pp. : 50-63

Maney Publishing

Access to resources Recommend Favorite

Mouse Models of Primary Sjogren’s Syndrome

Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. : 2350-2364

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Transgenic Mouse Models to Understand the Origins of Familial Pulmonary Fibrosis

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 9, 2011-01 ,pp. : 1447-1454

Bentham Science Publishers

Access to resources Recommend Favorite